EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Pfizer (NYSE:PFE) Rating Increased to Buy at Wall Street Zen
Medicus Pharma CEO on SkinJect and Pfizer partnership - ICYMI
The Manufacturers Life Insurance Company Lowers Stock Holdings in Pfizer Inc. $PFE
WINTON GROUP Ltd Purchases New Holdings in Pfizer Inc. $PFE - Stock Observer
The 10-Year Treasury Pays Nearly 5% These 6 Dividend Stocks Still Pay More
Former FDA Chief Gottlieb Trashed COVID-19 Seroprevalence Studies, Memo Reveals - NaturalNews.com
Integrated Wealth Concepts LLC Has $11.05 Million Position in Pfizer Inc. $PFE - Daily Political
Novavax Highlights Sanofi, Pfizer Catalysts in Matrix-M Platform Pivot
Pfizer Stock Or Zoetis: Is The Comeback Worth Paying Up For?
Tidal Investments LLC Has $47.48 Million Stock Holdings in Pfizer Inc. $PFE
Waverly Advisors LLC Has $12.80 Million Stock Holdings in Pfizer Inc. $PFE - Markets Daily
Pfizer (PFE) versus Its Peers Financial Review - Stock Observer
Novartis India zooms 51% in 3 days; what's driving the pharma stock? | Markets News - Business Standard
Pfizer Inc. $PFE Shares Bought by Waverly Advisors LLC - Stock Observer
Eosinophilic Esophagitis Market: Rapid Increment Driven by Innovation by 2036 - DelveInsight | Regeneron, Sanofi, Bristol-Myers Squibb, Ellodi Pharma, AstraZeneca, Allakos, EsoCap AG, Pfizer, Ception | ABNewswire
Type 2 Diabetes Market Growth Outlook 2036: Epidemiology, Pipeline Therapies, and Revenue Forecast - DelveInsight | Eli Lilly, Regor Pharma, AstraZeneca, Eccogene, Pfizer, Sciwind Biosciences | ABNewswire
Sickle Cell Disease Clinical Trial Pipeline: Emerging Therapies and Key Developments Shaping the Treatment Landscape | DelveInsight | ABNewswire
Metastatic Hormone Refractory Prostate Cancer Clinical Trial Pipeline Appears Robust With 180+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight | ABNewswire
Jim Cramer Picks J&J (JNJ) Over Eli Lilly (LLY) and Pfizer (PFE) Among These Healthcare Stocks
Deals/M&As: Medicus takes on Pfizer's ADC; Abbvie-Apogee M&A closes
Novartis-Pfizer trademark deal has opposite impact on their stock prices; Novartis India jumps 20% while Pfizer slips 3%
Allworth Financial LP Cuts Stake in Pfizer Inc. $PFE
Novartis India shares zoom 20% to hit record high; Minipress deal fuels rally
RBC Capital downgrades GlaxoSmithKline (GSK) to a Hold
RBC Capital Reaffirms Their Buy Rating on AstraZeneca (AZN)
Myeloperoxidase inhibition with mitiperstat in heart failure with preserved or mildly reduced ejection fraction: a randomized phase 2b trial
RBC Capital Initiates a Hold Rating on Sanofi (SNYNF)
Pfizer (NYSE:PFE) Stock Price Down 2.4% - Here's What Happened
Pfizer (NYSE:PFE) Stock Price Down 2.4% - Should You Sell?
Why Pfizer Stock Was so Healthy in August
Volumes spurt at Pfizer Ltd counter
Cygnus Capital Advisors LLC Reduces Stock Holdings in Pfizer Inc. $PFE
Pfizer shares hit 52 week low after Minipress XL discontinuation; Novartis zooms 13% - BusinessToday
Novartis India Acquires Pfizer's Minipress Brand for ₹1250 Crore Amidst Pharma Challenges, ETPharma
Forget the Dividend. This Could Be the Real Reason to Buy Pfizer Stock Now
This Is What I'd Do With Pfizer Stock Right Now
Novartis India Ltd to acquire BP drug trademarks from Pfizer Inc, for ₹1,250 crore
Novartis India acquires Pfizer trademarks for Rs 1,250 crore
Novartis India buys Minipress brands from Pfizer for ₹1,250 crore
The Second Act of Biotech
Vaccines Global Market Intelligence Report 2026-2035 Featuring Bio Farma, Emergent BioSolutions, GC Pharma, GlaxoSmithKline, Janssen, Merck, Novavax, Moderna, Pfizer, Sanofi Pasteur, and Valneva
Novartis India Acquires Pfizer's Minipress for ₹1,250 Cr
Novartis India to acquire Pfizer's 'Minipress' trademark for ₹1,250 crore
Travis Kelce's $320 billion brand endorsements sparked fierce outrage as critics questioned his choices
Saudi Central Bank Increases Stock Position in Pfizer Inc. $PFE
Rose Capital Advisors LLC Invests $905,000 in Pfizer Inc. $PFE
Pfizer (NYSE:PFE) Shares Down 1.4% - What's Next?
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
Pfizer's Stock Has Been Crushed-Is Its 6% Dividend Finally Worth Buying?
AMGN's MariTide: Can Convenience Drive its Obesity Market Share?
Pfizer (NYSE:PFE) Shares Up 1.7% - What's Next?
Texas attorney general pushes to revive Pfizer lawsuit over vaccine efficacy claims - NaturalNews.com
Pfizer (PFE) Stock Looks Overvalued After Updated COVID Vaccine Approval
Pharmaceutical Stocks To Follow Now - September 3rd - Stock Observer
Concurrent Investment Advisors LLC Has $21.47 Million Holdings in Pfizer Inc. $PFE - Stock Observer
Pfizer (PFE) Stock Looks Fully Valued As Earnings Run Ahead Of Value
Pfizer (PFE) After FDA Vaccine Approval Faces A Fair Value Reality Check
Inflammation as a therapeutic target to improve kidney and cardiovascular outcomes
3 Things You Need to Know If You Buy Pfizer Stock Today
Pharmaceutical Stocks To Follow Now - September 3rd - Zolmax
Pfizer (PFE) Up 12.4% Since Last Earnings Report: Can It Continue?
Pfizer's Pipeline Strategy Centers on Obesity and Oncology
Nykredit A S Invests $205.77 Million in Pfizer Inc. $PFE
Pfizer Inc. $PFE Holdings Decreased by Northwestern Mutual Wealth Management Co.
Top Dividend Stocks To Consider - September 2nd - Stock Observer
Why Did PFE, GTLB, COP Stocks Jump To 52-Week Highs Today?
iSAM Funds UK Ltd Buys 38,914 Shares of Pfizer Inc. $PFE - Daily Political
If You Want to Live, Stop Trusting the FDA, CDC, Corporate Media, and Jab-Pushing Doctors
Prevalence of BRCA1/2 variants in an Ovarian Cancer Cohort: outcomes from a Nationwide Testing Program
Updated COVID-19 vaccines are coming this fall. Will insurance cover them?
Pfizer (NYSE:PFE) Stock Price Up 1.7% - Should You Buy?
Can AI Save Pfizer Stock Before Its Patent Cliff Hits?
3 AI Stocks To Watch With Up To 45% Earnings Growth
Pfizer (NYSE:PFE) Shares Up 1.7% - Here's Why - Stock Observer
Should You Buy Pfizer Stock Below $30?
2 Absurdly Cheap Dividend Stocks to Buy With $1,000 Right Now
Nan Shan Life Insurance Co. Ltd. Increases Stock Holdings in Pfizer Inc. $PFE - Zolmax
Nan Shan Life Insurance Co. Ltd. Increases Position in Pfizer Inc. $PFE
Pfizer (PFE) Following FDA Vaccine Approval Has Fair Value Back In Focus
Why Did PFE, MMED, DE Stocks Surge To 52-Week Highs Today?
Pfizer Sees Unusually Large Options Volume (NYSE:PFE)
Fifth Circuit might inject new life into Texas' Covid-19 vaccine lawsuit | Courthouse News Service
Pfizer (NYSE:PFE) Hits New 52-Week High - What's Next?
Best Pharmaceutical Stocks To Consider - September 1st - Stock Observer
CFO Turnover at AT&T, Caterpillar, and Pfizer Sparked Rallies. Here's Why Rivian's Didn't.
Clifford Swan Investment Counsel LLC Lowers Position in Pfizer Inc. $PFE - Stock Observer
Pfizer (NYSE:PFE) Trading Up 2% - Time to Buy?
Pfizer (PFE) Reaches Confidential Settlement In Depo Provera Litigation
Cancer drug prices to drop as Ruto announces Pfizer deal
3 Stocks for Investors Who Still Believe Cash Is King
From Padcev to PF-08634404: Pfizer's Oncology Growth Push
PFIZER news
Trump Announces 25% Tariffs on Automobiles, Pharmaceuticals, and Semiconductors
Week Ahead: US And Canada Labour Markets Are In Focus, BoE Rate Decision
Latest news
Show more
Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty
September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations
Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge
